MET - MetLife Inc Stock Price, Fair Value and News

71.66USD+0.40 (+0.56%)Market Closed

Market Summary

USD71.66+0.40

Market Closed

0.56%

MET Alerts

Big jump in Earnings (Y/Y)

MET Stock Price

View Fullscreen

MET RSI Chart

MET Valuation

Market Cap

51.0B

Price/Earnings (Trailing)

21.55

Price/Sales (Trailing)

0.75

EV/EBITDA

7.81

Price/Free Cashflow

3.63

MET Price/Sales (Trailing)

MET Profitability

EBT Margin

4.37%

Return on Equity

8.21%

Return on Assets

0.35%

Free Cashflow Yield

27.52%

MET Fundamentals

MET Revenue

Revenue (TTM)

67.6B

Rev. Growth (Yr)

4.35%

Rev. Growth (Qtr)

-15.61%

MET Earnings

Earnings (TTM)

2.4B

Earnings Growth (Yr)

983.75%

Earnings Growth (Qtr)

42.83%

Breaking Down MET Revenue

Last 7 days

-0.3%

Last 30 days

-2.9%

Last 90 days

7.4%

Trailing 12 Months

35.8%

How does MET drawdown profile look like?

MET Financial Health

Debt/Equity

0.66

Debt/Cashflow

0.74

MET Investor Care

Dividend Yield

2.9%

Dividend/Share (TTM)

2.08

Buy Backs (1Y)

7.14%

Diluted EPS (TTM)

2.91

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	67.6B	0	0	0
2023	68.8B	69.9B	63.5B	66.9B
2022	68.5B	65.5B	70.9B	68.8B
2021	65.1B	69.5B	70.4B	68.7B
2020	71.6B	68.2B	65.6B	67.8B
2019	69.4B	65.8B	68.1B	69.6B
2018	62.1B	68.0B	68.1B	67.9B
2017	59.5B	58.8B	59.1B	62.3B
2016	61.2B	63.0B	62.9B	60.6B
2015	72.5B	68.4B	65.5B	61.3B
2014	67.6B	70.1B	72.7B	73.3B
2013	69.9B	67.2B	67.1B	68.2B
2012	70.3B	71.5B	67.6B	68.2B
2011	55.1B	58.1B	66.2B	70.2B
2010	43.9B	49.8B	51.9B	52.2B
2009	49.6B	45.8B	42.7B	41.1B
2008	0	48.4B	49.7B	51.0B
2007	0	0	0	47.2B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022

Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of MetLife Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 01, 2024	hay laura j	acquired	43,771	73.69	594	-
Apr 01, 2024	kinney catherine r	acquired	-	-	594	-
Apr 01, 2024	johnson jeh c.	acquired	43,771	73.69	594	-
Apr 01, 2024	herzog david l	acquired	-	-	594	-
Apr 01, 2024	hubbard robert glenn	acquired	75,016	73.69	1,018	-
Apr 01, 2024	grise cheryl w	acquired	43,771	73.69	594	-
Apr 01, 2024	kelly edward j iii	acquired	43,771	73.69	594	-
Apr 01, 2024	hassell gerald l	acquired	43,771	73.69	594	-
Apr 01, 2024	mckenzie diana	acquired	43,771	73.69	594	-
Apr 01, 2024	harris carla a	acquired	43,771	73.69	594	-

Which funds bought or sold MET recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 07, 2024	M&T Bank Corp	reduced	-2.59	5,239,920	62,372,300	0.22%
May 07, 2024	CarsonAllaria Wealth Management, Ltd.	added	0.96	1,787	15,666	0.01%
May 07, 2024	Washington Trust Advisors, Inc.	added	27.23	11,377	38,094	-%
May 07, 2024	WestEnd Advisors, LLC	new	-	148	148	-%
May 07, 2024	Americana Partners, LLC	reduced	-1.58	106,070	1,136,750	0.10%
May 07, 2024	Gibraltar Capital Management, Inc.	sold off	-100	-747,467	-	-%
May 07, 2024	Advantage Trust Co	unchanged	-	4,828	44,837	0.03%
May 07, 2024	OPPENHEIMER ASSET MANAGEMENT INC.	reduced	-12.11	-95,163	6,213,310	0.09%
May 07, 2024	ClariVest Asset Management LLC	reduced	-25.00	-975	5,111	-%
May 07, 2024	Legacy Capital Group California, Inc.	reduced	-1.3	30,792	320,970	0.12%

Are Funds Buying or Selling MET?

Are funds buying MET calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own MET

No. of Funds

MET Alerts

Big jump in Earnings (Y/Y)

Unveiling MetLife Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
May 02, 2024	board of directors of metlife inc	16.2%	115,248,427	SC 13D/A
Feb 15, 2024	board of directors of metlife inc	16.2%	116,905,555	SC 13D/A
Feb 13, 2024	dodge & cox	7.2%	53,443,191	SC 13G/A
Feb 13, 2024	vanguard group inc	7.79%	57,648,051	SC 13G/A
Jan 26, 2024	blackrock inc.	7.1%	52,733,080	SC 13G/A
Nov 02, 2023	board of directors of metlife inc	16.0%	118,254,445	SC 13D/A
Aug 04, 2023	board of directors of metlife inc	16.0%	120,043,226	SC 13D/A
May 04, 2023	board of directors of metlife inc	15.9%	121,521,424	SC 13D/A
Feb 23, 2023	board of directors of metlife inc	15.9%	122,923,807	SC 13D/A
Feb 14, 2023	dodge & cox	6.8%	53,583,210	SC 13G/A

Recent SEC filings of MetLife Inc

View All Filings

Date Filed	Form Type	Document
May 08, 2024	PX14A6G	PX14A6G
May 02, 2024	10-Q	Quarterly Report
May 02, 2024	SC 13D/A	13D - Major Acquisition
May 01, 2024	8-K	Current Report
Apr 26, 2024	ARS	ARS
Apr 26, 2024	DEF 14A	DEF 14A
Apr 26, 2024	DEFA14A	DEFA14A
Apr 03, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading

Peers (Alternatives to MetLife Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ARGO	1.0T	1.3B	-3.06%	3200.44%	-4.9K	773.83	-10.27%	-34.69%
AJG	53.5B	10.6B	0.35%	13.39%	49.03	5.04	20.42%	-6.05%
AIG	53.0B	48.4B	2.59%	50.41%	10.98	1.1	-4.15%	-20.63%
TRV	49.8B	42.9B	-5.78%	18.24%	15.85	1.16	13.52%	12.15%
AFL	48.2B	19.3B	-0.38%	25.81%	9.01	2.49	3.03%	17.35%
ACGL	37.0B	13.6B	4.64%	29.15%	8.33	2.72	41.83%	201.02%
AFG	11.0B	8.0B	-2.14%	12.66%	12.42	1.37	11.14%	7.56%
MID-CAP
UNM	10.0B	12.6B	-1.30%	18.66%	7.54	0.79	4.24%	-13.40%
AIZ	9.2B	11.1B	-2.63%	35.17%	14.28	0.82	9.21%	132.28%
LNC	5.0B	11.9B	-5.15%	39.72%	3.69	0.42	-33.27%	234.43%
AEL	4.5B	2.8B	-0.20%	45.14%	21.34	1.58	100.59%	-89.04%
SMALL-CAP
BRP	1.9B	1.3B	8.10%	32.13%	-35.66	1.53	18.74%	30.90%
AMSF	908.5M	308.9M	-0.11%	-15.37%	14.73	2.94	3.79%	10.94%
AMBC	828.5M	314.0M	15.44%	22.21%	14.41	2.64	-29.20%	-88.19%
AAME	37.3M	186.8M	-15.67%	-17.10%	-218.34	0.2	-0.56%	-111.21%

MetLife Inc News

Latest updates

MetLife Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-15.6%	16,057	19,028	15,866	16,623	15,388	15,608	22,283	15,474	15,405	17,705	16,905	18,524	15,562	19,418	16,015	14,099	18,310	17,143	18,678	17,497	16,302
Operating Expenses	-3.0%	3,217	3,316	3,204	3,133	3,057	4.00	2,922	2,908	2,952	10.00	3,284	2,881	3,150	3,424	3,470	2,983	3,273	3,631	3,443	3,390	3,225
EBITDA Margin	25.3%	0.06*	0.05*	0.07*	0.07*	0.08*	0.11*	0.10*	0.12*	0.16*	0.14*	0.11*	0.10*	-	-	-	-	-	-	-	-	-
Interest Expenses	-25.7%	231	311	206	289	183	314	156	285	150	308	166	287	153	312	153	290	136	317	137	362	148
Income Taxes	-48.0%	170	327	39.00	22.00	172	-67.00	248	73.00	296	-34.00	453	1,075	-72.00	6.00	214	47.00	1,242	-625	601	551	359
Earnings Before Taxes	11.1%	1,045	941	534	430	257	2,026	1,415	988	1,935	1,698	2,042	4,487	291	164	923	197	5,643	-37.00	2,791	2,297	1,744
EBT Margin	35.1%	0.04*	0.03*	0.05*	0.06*	0.07*	0.09*	0.09*	0.10*	0.15*	0.12*	0.10*	0.08*	-	-	-	-	-	-	-	-	-
Net Income	42.8%	867	607	489	402	80.00	1,578	1,162	910	1,634	1,504	1,584	3,407	363	158	706	145	4,401	593	2,184	1,741	1,381
Net Income Margin	48.4%	0.03*	0.02*	0.04*	0.05*	0.05*	0.08*	0.07*	0.09*	0.12*	0.10*	0.08*	0.07*	-	-	-	-	-	-	-	-	-
Free Cashflow	-55.1%	2,328	5,182	3,475	3,038	2,026	2,301	4,310	4,393	2,040	5,091	3,506	2,254	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-1.5%	677,576	687,584	652,120	677,279	674,266	663,072	650,104	662,893	724,284	759,708	761,664	773,253	769,814	795,146	780,492	767,583	737,741	740,463	742,812	732,167	713,188
Cash Equivalents	-3.9%	19,840	20,639	14,912	15,417	18,456	20,195	22,200	20,548	23,488	20,047	18,956	25,037	19,635	19,795	24,405	24,289	24,094	16,598	19,452	18,435	14,506
Goodwill	-2.2%	9,037	9,236	9,109	9,261	9,379	9,297	9,005	9,151	9,510	9,535	9,638	9,768	9,944	10,112	9,360	9,245	9,159	9,308	9,278	9,408	9,418
Liabilities	-1.3%	648,780	657,331	626,225	646,787	641,843	632,947	624,774	625,526	670,047	691,959	692,331	703,830	703,677	720,329	706,923	691,643	667,278	674,081	674,193	668,121	654,450
Short Term Borrowings	6.7%	127	119	161	200	168	175	183	196	323	341	346	393	302	393	351	303	298	235	142	158	289
Shareholder's Equity	-4.1%	28,796	30,015	25,658	30,492	32,423	29,881	29,640	34,009	42,703	50,013	69,333	69,423	66,137	74,817	73,569	75,940	70,463	66,382	68,619	64,046	58,738
Retained Earnings	0.5%	40,350	40,146	39,958	39,928	39,957	40,332	41,032	41,101	41,406	41,197	40,426	39,318	36,373	31,824	36,782	36,568	36,919	33,078	32,948	31,209	29,944
Additional Paid-In Capital	0.1%	33,718	33,690	33,666	33,630	33,617	33,616	33,589	33,548	33,531	33,511	33,457	33,440	33,910	33,812	33,744	33,728	33,711	32,680	32,639	32,602	32,535
Shares Outstanding	-2.1%	716	731	744	757	769	779	787	798	815	826	845	861	-	-	-	-	-	-	-	-	-
Minority Interest	9.7%	261	238	237	231	229	244	254	266	272	267	283	285	273	259	253	247	242	238	251	235	229
Float	-	-	-	-	42,800	-	-	-	50,100	-	-	-	51,500	-	-	-	33,100	-	-	-	46,500	-

Cashflow (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-55.1%	2,328	5,182	3,475	3,038	2,026	2,301	4,310	4,393	2,040	5,091	3,506	2,254	1,496	5,153	3,793	846	1,847	5,181	4,146	2,387	2,072
Cashflow From Investing	-556.1%	-2,627	576	-2,972	-6,346	-1,504	-197	-4,112	2,115	-426	-2,862	-8,280	1,009	-1,054	-2,162	-6,679	-1,391	-8,337	-7,093	-5,351	557	-5,699
Cashflow From Financing	-48.3%	-261	-176	-848	379	-2,295	-4,468	1,743	-9,088	1,865	-1,086	-1,108	1,632	-564	-6,993	2,885	680	14,157	-1,009	2,327	934	2,316
Dividend Payments	-2.3%	377	386	392	399	389	393	400	408	397	405	413	421	408	415	419	419	404	406	413	419	405
Buy Backs	36.4%	1,172	859	792	672	780	596	674	1,116	940	1,176	1,015	1,113	999	571	80.00	-	500	250	785	750	500

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

MET Income Statement

2024-03-31

Consolidated Statements of Operations and Comprehensive Income (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues
Premiums	$ 10,053	$ 9,589
Universal life and investment-type product policy fees	1,248	1,289
Net investment income	5,436	4,645
Other revenues	674	639
Net investment gains (losses)	(375)	(684)
Net derivative gains (losses)	(979)	(90)
Total revenues	16,057	15,388
Expenses
Policyholder benefits and claims	10,074	9,872
Policyholder liability remeasurement (gains) losses	(22)	(9)
Market risk benefit remeasurement (gains) losses	(694)	188
Interest credited to policyholder account balances	2,290	1,864
Policyholder dividends	147	159
Other expenses	3,217	3,057
Total expenses	15,012	15,131
Income (loss) before provision for income tax	1,045	257
Provision for income tax expense (benefit)	170	172
Net income (loss)	875	85
Less: Net income (loss) attributable to noncontrolling interests	8	5
Net income (loss) attributable to MetLife, Inc.	867	80
Dividends, Preferred Stock	67	66
Net income (loss) available to MetLife, Inc.’s common shareholders	800	14
Comprehensive income (loss)	347	3,541
Less: Comprehensive income (loss) attributable to noncontrolling interests, net of income tax	9	(13)
Comprehensive income (loss) attributable to MetLife, Inc.	$ 338	$ 3,554
Net income (loss) available to MetLife, Inc.’s common shareholders per common share:
Basic	$ 1.11	$ 0.02
Diluted	$ 1.10	$ 0.02

MET Balance Sheet

2024-03-31

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Investments:
Fixed maturity securities available-for-sale, at estimated fair value (net of allowance for credit loss of $113 and $184, respectively); and amortized cost: $300,623 and $300,555, respectively	$ 278,409	$ 281,412
Equity securities	750	757
Contractholder-directed equity securities and fair value option securities, at estimated fair value	10,313	10,331
Mortgage loans (net of allowance for credit loss of $814 and $721, respectively)	91,458	92,506
Policy loans	8,800	8,788
Real estate and real estate joint ventures (includes $328 and $317, respectively, under the fair value option)	12,992	13,332
Other limited partnership interests	14,301	14,764
Short-term investments, principally at estimated fair value	4,884	6,045
Other invested assets (includes $1,843 and $1,993, respectively, of leveraged and direct financing leases; $432 and $333, respectively, relating to variable interest entities)	18,097	18,202
Total investments	440,004	446,137
Cash and cash equivalents, principally at estimated fair value	19,840	20,639
Accrued investment income	3,636	3,589
Premiums, reinsurance and other receivables	29,986	28,971
Market risk benefits	351	286
Deferred policy acquisition costs and value of business acquired	19,842	20,151
Current income tax recoverable	0	190
Deferred income tax asset	2,751	2,612
Goodwill	9,037	9,236
Other assets	11,126	11,139
Separate account assets	141,003	144,634
Total assets	677,576	687,584
Liabilities
Future policy benefits	191,013	196,406
Policyholder account balances	219,168	219,269
Market risk benefits	2,696	3,179
Other policy-related balances	20,219	19,736
Policyholder dividends payable	357	386
Payables for collateral under securities loaned and other transactions	17,470	17,524
Short-term debt	127	119
Long-term debt (includes $26 and $0, respectively, relating to variable interest entities)	15,972	15,548
Collateral financing arrangement	590	637
Junior subordinated debt securities	3,162	3,161
Current income tax payable	10	0
Deferred income tax liability	835	927
Other liabilities	36,158	35,805
Separate account liabilities	141,003	144,634
Total liabilities	648,780	657,331
Contingencies, Commitments and Guarantees (Note 19)
MetLife, Inc.’s stockholders’ equity:
Preferred stock, par value $0.01 per share; $3,905 aggregate liquidation preference	0	0
Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 1,193,562,132 and 1,191,823,651 shares issued, respectively; 715,661,353 and 730,821,111 shares outstanding, respectively	12	12
Additional paid-in capital	33,718	33,690
Retained earnings	40,350	40,146
Treasury stock, at cost; 477,900,779 and 461,002,540 shares, respectively	(25,774)	(24,591)
Accumulated other comprehensive income (loss)	(19,771)	(19,242)
Total MetLife, Inc.’s stockholders’ equity	28,535	30,015
Noncontrolling interests	261	238
Total equity	28,796	30,253
Total liabilities and equity	$ 677,576	$ 687,584

About MetLife Inc

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.

CEO	Mr. Michel Abbas Khalaf
WEBSITE	metlife.com
INDUSTRY	Insurance Property & Casualty
EMPLOYEES	45000

MetLife Inc Frequently Asked Questions

What is the ticker symbol for MetLife Inc? What does MET stand for in stocks?

MET is the stock ticker symbol of MetLife Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of MetLife Inc (MET)?

As of Wed May 08 2024, market cap of MetLife Inc is 50.96 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MET stock?

You can check MET's fair value in chart for subscribers.

What is the fair value of MET stock?

You can check MET's fair value in chart for subscribers. The fair value of MetLife Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of MetLife Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for MET so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is MetLife Inc a good stock to buy?

The fair value guage provides a quick view whether MET is over valued or under valued. Whether MetLife Inc is cheap or expensive depends on the assumptions which impact MetLife Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MET.

What is MetLife Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed May 08 2024, MET's PE ratio (Price to Earnings) is 21.55 and Price to Sales (PS) ratio is 0.75. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MET PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on MetLife Inc's stock?

In the past 10 years, MetLife Inc has provided 0.076 (multiply by 100 for percentage) rate of return.